ロード中...
Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis
BACKGROUND: Comprehensive evaluation of safety and efficacy of different combinations of direct‐acting antivirals (DAAs) in liver transplant recipients with genotype 1 (GT1) hepatitis C virus (HCV) recurrence remains limited. Therefore, we performed this systematic review and meta‐analysis in order...
保存先:
| 出版年: | Transpl Infect Dis |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850617/ https://ncbi.nlm.nih.gov/pubmed/30615227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|